AEHR TEST SYSTEMS Reports Strong First‑Quarter Fiscal 2027 Results, Boosts Outlook

AEHR, the Fremont‑based semiconductor testing equipment supplier, announced its first‑quarter fiscal 2027 financial results on November 2, 2026, delivering a sharp lift in both revenue and earnings that has propelled the stock higher in the days that followed.

Q1 2027 Performance

  • Revenue: $33.0 million, a $5.47 million increase over consensus and a tripling of FY 2026 revenue.
  • Non‑GAAP earnings per share: $0.28, beating estimates by $0.15.
  • Revenue beats: The company’s $33 million revenue surpassed analysts’ expectations by $5.47 million.
  • Backlog: The effective backlog climbed to $109.3 million, supported by $46.7 million in new quarterly bookings.

These figures were highlighted in a press release distributed via ACCESS Newswire, and subsequent commentary from financial analysts underscored the company’s robust performance.

Drivers of Growth

The company attributed its earnings surge largely to a sustained rise in demand for artificial‑intelligence (AI) chips, silicon photonics, data‑center, automotive and industrial memory devices. AEHR’s test‑and‑burn‑in solutions, designed to reduce testing costs for dynamic random‑access memory (DRAM) and other memory devices, have become increasingly critical as chip complexity grows.

In a statement shared by the CEO, the company emphasized that “AI chip complexity is accelerating burn‑in demand,” a sentiment echoed in a Benzinga article that described the stock’s surge on the day of the earnings release. The company’s systems enable integrated‑circuit manufacturers to perform test and burn‑in of bare dies, a capability that has become essential for meeting the reliability standards required by AI workloads.

Guidance and Outlook

AEHR has raised its fiscal‑2027 revenue outlook to $150 million, a three‑fold increase from the previous year. The company has also signaled a focus on achieving at least a 20% non‑GAAP net‑income margin for the year. Analysts noted that the company’s guidance reflects a healthy pipeline of AI orders and a strong backlog that should translate into continued revenue growth.

Market Reaction

The announcement triggered a 19% jump in the company’s shares, as reported by RTT News and corroborated by multiple market data feeds. The stock’s performance was also highlighted in the context of broader market movements on November 3, when the Nasdaq‑100 futures saw a modest gain of 0.46% amid mixed pre‑market activity. While the sector was under pressure from a declining Apple share price and concerns about memory‑chip costs, AEHR’s earnings beat and upward guidance provided a rallying point for semiconductor equities.

In summary, AEHR’s first‑quarter results demonstrate a compelling convergence of AI‑driven demand and the company’s specialized testing solutions, positioning it favorably for the remainder of fiscal 2027 and beyond.